Response to: Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
Main Authors: | Aytaç Atamer, Yildiz Atamer, Ahmet S Can |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2016;volume=22;issue=1;spage=84;epage=85;aulast=Atamer |
Similar Items
-
Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis
by: Aytac Atamer, et al.
Published: (2014-01-01) -
Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
by: Mehmet Agilli, et al.
Published: (2014-01-01) -
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
by: Y. Atamer, et al.
Published: (2013-06-01) -
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
by: Y. Atamer, et al.
Published: (2013-01-01) -
A Comparative Assessment of Serum Malondialdehyde Level and Paraoxonase Activity in Healthy and Kwashiorkor Children
by: Ravinder K Arora, et al.
Published: (2017-04-01)